The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder and inserts a radioactive substance to treat cancer; he may or may not destroy (fulgurate) or take samples of (biopsy) suspiciouis lesions for pathologic examination.
For clinical responsibility, terminology, tips and additional info
start codify free trial.